Our Research Publications
Updated August 2024
Pagination
- Previous page
- Page 15
- Next page
Title | Authors | Year Sort ascending | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
DNA Mediated Blood Coagulation: Extracellular DNA Accelerates Fibrinogen Polymerization By Thrombin Independent of Contact Pathway | Vappala S, Straus S, Pryzdial EL, Conway E, Kizhakkedathu J | 2021 | Blood | View DNA Mediated Blood Coagulation: Extracellular DNA Accelerates Fibrinogen Polymerization By Thrombin Independent of Contact Pathway | Researchers | Basic research |
Reconstituted cryopreserved platelets synthesize proteins during short-term storage and packaging a defined subset into microvesicles | Schubert P, Johnson L, Culibrk B, Chen Z, Tan S, Marks DC, Devine DV | 2021 | Transfusion | View Reconstituted cryopreserved platelets synthesize proteins during short-term storage and packaging a defined subset into microvesicles | Researchers | New or improved product or process |
Major clinical trial finds convalescent plasma does not help patients with COVID-19 | Modi D | 2021 | Ontario Regional Blood Coordinating Network December 2021 Newsletter | View Major clinical trial finds convalescent plasma does not help patients with COVID-19 | Health care providers | Clinical research |
A Higher Antibody Response Is Generated With a 6- to 7-Week (vs Standard) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Dosing Interval | Grunau B, Asamoah-Boaheng M, Lavoie PM, Karim ME, Kirkham TL, Demers PA, Barakauskas V, Marquez AC, Jassem AN, O'Brien SF, Drews SJ, Haig S, Cheskes S, Goldfarb DM | 2021 | Clin Infect Dis | View A Higher Antibody Response Is Generated With a 6- to 7-Week (vs Standard) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Dosing Interval | Researchers | Clinical research |
Chapter 6: Donor selection, donor testing and pathogen reduction | Drews S, Khandelwal A, Goldman M, Devine D | 2021 | Clinical Guide to Transfusion | View Chapter 6: Donor selection, donor testing and pathogen reduction | Health care providers | Benchmarking and standard setting |
Estimating the impact on the inventory of implementing pathogen-reduced platelets in Canada | Blake JT, McTaggart K, Couture C | 2021 | Transfusion | View Estimating the impact on the inventory of implementing pathogen-reduced platelets in Canada | Blood operators | Benchmarking and standard setting |
Compliance with the massive hemorrhage protocol in trauma: a retrospective quality review | Khayyat H, Callum JL, Hill-Strathy M, Strauss R, Notario L, Nathens A, da Luz L | 2021 | Can J Anaesth | View Compliance with the massive hemorrhage protocol in trauma: a retrospective quality review | Health care providers | Clinical research |
Registration errors among patients receiving blood transfusions: a national analysis from 2008 to 2017 | Vijenthira S, Armali C, Downie H, Wilson A, Paton K, Berry B, Wu HX, Robitaille A, Cserti-Gazdewich C, Callum J | 2021 | Vox Sang | View Registration errors among patients receiving blood transfusions: a national analysis from 2008 to 2017 | Health care providers | Clinical research |
Successful prenatal therapy for anti-CD36-mediated severe FNAIT by deglycosylated antibodies in a novel murine model | Xu X, Chen D, Ye X, Xia W, Xu Y, Chen Y, Shao Y, Deng J, Ding H, Liu J, Wang J, Ni H, Fu Y, Santoso S | 2021 | Blood | View Successful prenatal therapy for anti-CD36-mediated severe FNAIT by deglycosylated antibodies in a novel murine model | Researchers | Basic research |
Evaluating the Tactical Combat Casualty Care principles in civilian and military settings: systematic review, knowledge gap analysis and recommendations for future research | Strauss R, Menchetti I, Perrier L, Blondal E, Peng H, Sullivan-Kwantes W, Tien H, Nathens A, Beckett A, Callum J, da Luz LT | 2021 | Trauma Surg Acute Care Open | View Evaluating the Tactical Combat Casualty Care principles in civilian and military settings: systematic review, knowledge gap analysis and recommendations for future research | Health care providers | Clinical research |
Chapitre 15: Composants sanguins négatifs pour les anti-CMV, irradiés et lavéss | Prokopchuk-Gauk O, Solh Z | 2021 | Guide de la pratique transfusionnelle | View Chapitre 15: Composants sanguins négatifs pour les anti-CMV, irradiés et lavéss | Health care providers | Benchmarking and standard setting |
SARS-CoV-2 seroprevalence among Vancouver public school staff in British Columbia, Canada | Goldfarb DM, Mâsse LC, Watts AW, Hutchison SM, Muttucomaroe L, Bosman ES, Barakauskas VE, Choi A, Irvine MA, Reicherz F, Coombs D, O’Reilly C, Sediqi S, Razzaghian HR, Sadarangani M, O’Brien SF, Lavoie PM | 2021 | medRxiv | View SARS-CoV-2 seroprevalence among Vancouver public school staff in British Columbia, Canada | Researchers | Clinical research |
Concentré de recherche: Transfusion de plaquettes chez les enfants atteints de cancer | Barty R | 2021 | Blood.ca website | View Concentré de recherche: Transfusion de plaquettes chez les enfants atteints de cancer | Health care providers | Benchmarking and standard setting |
A Higher Antibody Response Is Generated With a 6- to 7-Week (vs Standard) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Dosing Interval | Grunau B, Asamoah-Boaheng M, Lavoie PM, Karim ME, Kirkham TL, Demers PA, Barakauskas V, Marquez AC, Jassem AN, O’Brien SF, Drews SJ, Haig S, Cheskes S, Goldfarb DM | 2021 | Clin Infect Dis | View A Higher Antibody Response Is Generated With a 6- to 7-Week (vs Standard) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Dosing Interval | Researchers | Clinical research |
COVID-19 convalescent plasma: Interim recommendations from the AABB | Cohn CS, Estcourt L, Grossman BJ, Pagano MB, Allen ES, Bloch EM, Casadevall A, Devine DV, Dunbar NM, Foroutan F, Gniadek TJ, Goel R, Gorlin J, Joyner MJ, Metcalf RA, Raval JS, Rice TW, Shaz BH, Vassallo RR, Winters JL, Beaudoin G, Tobian AAR | 2021 | Transfusion | View COVID-19 convalescent plasma: Interim recommendations from the AABB | Health care providers | Clinical research |
Evaluation of a pre-exposure prophylaxis (PrEP)/post-exposure prophylaxis (PEP) deferral policy among blood donors | Saeed S, Goldman M, Uzicanin S, O'Brien SF | 2021 | Transfusion | View Evaluation of a pre-exposure prophylaxis (PrEP)/post-exposure prophylaxis (PEP) deferral policy among blood donors | Blood operators | New or improved product or process |
Persistence of CRISPR/Cas9 gene edited hematopoietic stem cells following transplantation: A systematic review and meta-analysis of preclinical studies | Maganti HB, Bailey AJM, Kirkham AM, Shorr R, Pineault N, Allan DS | 2021 | Stem Cells Transl Med | View Persistence of CRISPR/Cas9 gene edited hematopoietic stem cells following transplantation: A systematic review and meta-analysis of preclinical studies | Researchers | Basic research |
Translating bioactive peptides for COVID-19 therapy | Bhullar KS, Drews SJ, Wu J | 2021 | Eur J Pharmacol | View Translating bioactive peptides for COVID-19 therapy | Researchers | Basic research |
Concentré de recherche: Saignement pendant la chirurgie cardiaque?: le?concentré de complexe prothrombique est-il une solution de rechange au plasma? | Kron A | 2021 | Blood.ca website | View Concentré de recherche: Saignement pendant la chirurgie cardiaque?: le?concentré de complexe prothrombique est-il une solution de rechange au plasma? | Health care providers | Clinical research |
Maintaining trust in a pandemic: Blood collection agency messaging to donors and the public during the early days of COVID-19 | Haw J, Thorpe R, Holloway K | 2021 | SocArXiv | View Maintaining trust in a pandemic: Blood collection agency messaging to donors and the public during the early days of COVID-19 | Blood operators | Ethical, legal and social implications research |
COVID-19 Case Age Distribution: Correction for Differential Testing by Age | Fisman DN, Greer A, Brankston G, Hillmer M, O'Brien SF, Drews S, Tuite AR | 2021 | Ann Intern Med | View COVID-19 Case Age Distribution: Correction for Differential Testing by Age | Researchers | Clinical research |
Ketamine administration for acute painful sickle cell crisis: A randomized controlled trial | Alshahrani MS, AlSulaibikh AH, ElTahan MR, AlFaraj SZ, Asonto LP, AlMulhim AA, AlAbbad MF, Almaghraby N, AlJumaan MA, AlJunaid TO, Darweesh MN, AlHawaj FM, Mahmoud AM, Alossaimi BK, Alotaibi SK, AlMutairi TM, AlSulaiman Pharm DD, Alfaraj D, Alhawwas R, Mbuagbaw L, Lewis K, Verhovsek M, Crowther M, Guyatt G, Alhazzani W | 2021 | Acad Emerg Med | View Ketamine administration for acute painful sickle cell crisis: A randomized controlled trial | Researchers | Clinical research |
Coagulation factor VIIa binds to herpes simplex virus 1-encoded glycoprotein C forming a factor X-enhanced tenase complex oriented on membranes | Lin BH, Sutherland MR, Rosell FI, Morrissey JH, Pryzdial ELG | 2020 | J Thromb Haemost | View Coagulation factor VIIa binds to herpes simplex virus 1-encoded glycoprotein C forming a factor X-enhanced tenase complex oriented on membranes | Researchers | Basic research |
Approach to red blood cell antibody testing during pregnancy: Answers to commonly asked questions | Minuk L, Clarke G, Lieberman L | 2020 | Can Fam Physician | View Approach to red blood cell antibody testing during pregnancy: Answers to commonly asked questions | Health care providers | Clinical research |
Fetal/neonatal alloimmune thrombocytopenia: a systematic review of impact of HLA-DRB3*01:01 on fetal/neonatal outcome | Kjeldsen-Kragh J, Fergusson DA, Kjaer M, Lieberman L, Greinacher A, Murphy MF, Bussel J, Bakchoul T, Corke S, Bertrand G, Oepkes D, Baker JM, Hume H, Massey E, Kaplan C, Arnold DM, Baidya S, Ryan G, Savoia HF, Landry D, Shehata N | 2020 | Blood Adv | View Fetal/neonatal alloimmune thrombocytopenia: a systematic review of impact of HLA-DRB3*01:01 on fetal/neonatal outcome | Health care providers | Clinical research |
L’exploration des frontières de l’hémolyse associée aux IgIV | Pendergrast J, Branch D | 2020 | Blood.ca website | View L’exploration des frontières de l’hémolyse associée aux IgIV | Health care providers | Benchmarking and standard setting |
Pre-transfusion Testing | Duncan J | 2020 | Clinical Guide to Transfusion | View Pre-transfusion Testing | Health care providers | Benchmarking and standard setting |
Stabilization of Lipid Membranes through Partitioning of the Blood Bag Plasticizer Di-2-ethylhexyl phthalate (DEHP) | Bider R-C, Lluka T, Himbert S, Khondker A, Qadri SM, Sheffield WP, Rheinstädter MC | 2020 | Langmuir | View Stabilization of Lipid Membranes through Partitioning of the Blood Bag Plasticizer Di-2-ethylhexyl phthalate (DEHP) | Researchers | Basic research |
Vox Sanguinis International Forum on Donor Incentives: Summary | Zeller MP, Ellingham D, Devine D, Lozano M, Lewis P, Zhiburt E, van der Linde L, Goldman M, Nakamura A, Inoue S, Takikawa M, Nakajima K, Turek P, Rehacek V, Sakashita AM, Kutner JM, Karim FA, Hindawi S, Jayasekara SBA, Merz EM, Gross S, Woimant G, Djoudi R, Byabazaire KD, Irving DO, Abdrakhmanova S, Khalykova A, Yilmaz S, Oruc NE, Huaynalaya IP, Ramirez LAS, Chuhriiev A | 2020 | Vox Sang | View Vox Sanguinis International Forum on Donor Incentives: Summary | Blood operators | Benchmarking and standard setting |
An activator of G protein-coupled receptor and MEK1/2-ERK1/2 signaling inhibits HIV-1 replication by altering viral RNA processing | Wong RW, Balachandran A, Cheung PK, Cheng R, Pan Q, Stoilov P, Harrigan PR, Blencowe BJ, Branch DR, Cochrane A | 2020 | PLoS Pathog | View An activator of G protein-coupled receptor and MEK1/2-ERK1/2 signaling inhibits HIV-1 replication by altering viral RNA processing | Researchers | Basic research |
HIV residual risk in Canada under a three-month deferral for men who have sex with men | O'Brien SF, Gregoire Y, Pillonel J, Steele WR, Custer B, Davison KL, Germain M, Lewin A, Seed CR | 2020 | Vox Sang | View HIV residual risk in Canada under a three-month deferral for men who have sex with men | Researchers | Other |
Blood System Inventory Management Best Practices Guide | Clarke G, Romans R | 2020 | Blood.ca website | Health care providers | Benchmarking and standard setting | |
Concentré de recherche: Estimation de la prévalence de l’hémophilie et de l’espérance de vie | Iorio A | 2020 | Blood.ca website | Health care providers | Clinical research | |
Effects of the COVID-19 pandemic on supply and use of blood for transfusion | Stanworth SJ, New HV, Apelseth TO, Brunskill S, Cardigan R, Doree C, Germain M, Goldman M, Massey E, Prati D, Shehata N, So-Osman C, Thachil J | 2020 | Lancet Haematol | View Effects of the COVID-19 pandemic on supply and use of blood for transfusion | Health care providers | Clinical research |
Mucosal versus systemic antibody responses to SARS-CoV-2 antigens in COVID-19 patients | Isho B, Abe KT, Zuo M, Jamal AJ, Rathod B, Wang JH, Li Z, Chao G, Rojas OL, Bang YM, Pu A, Christie-Holmes N, Gervais C, Ceccarelli D, Samavarchi-Tehrani P, Guvenc F, Budylowski P, Li A, Paterson A, Yun YF, Marin LM, Caldwell L, Wrana JL, Colwill K, Sicheri F, Mubareka S, Gray-Owen SD, Drews SJ, Siqueira WL, Barrios-Rodiles M, Ostrowski M, Rini JM, Durocher Y, McGeer AJ, Gommerman JL, Gingras A-C | 2020 | medRxiv | View Mucosal versus systemic antibody responses to SARS-CoV-2 antigens in COVID-19 patients | Researchers | Basic research |
Thrombotic Thrombocytopenic Purpura | Crowther M, Zawilska K, Mlynarski W, Arnold D | 2020 | McMaster Textbook of Internal Medicine | Health care providers | Benchmarking and standard setting | |
Educating the next frontier of transfusionists: a transfusion camp pilot program for nurse practitioners | Shih AW, Morrison D, Sekhon AS, Lin Y, Charge S, Chipperfield K, Beaveridge J | 2020 | Transfusion | View Educating the next frontier of transfusionists: a transfusion camp pilot program for nurse practitioners | Health care providers | Other |
Influenza increases invasive meningococcal disease risk in temperate countries | Salomon A, Berry I, Tuite AR, Drews S, Hatchette T, Jamieson F, Johnson C, Kwong J, Lina B, Lojo J, Mosnier A, Ng V, Vanhems P, Fisman DN | 2020 | Clin Microbiol Infect | View Influenza increases invasive meningococcal disease risk in temperate countries | Health care providers | Clinical research |
Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates fibrin-dependent plasmin generation on thrombin-activated platelets | Ni R, Neves MAD, Wu C, Cerroni SE, Flick MJ, Ni H, Weitz JI, Gross PL, Kim PY | 2020 | Thromb Haemost | View Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates fibrin-dependent plasmin generation on thrombin-activated platelets | Researchers | Basic research |
Challenges and key lessons from the design and implementation of an international haemophilia registry supported by a pharmaceutical company | Hay CRM, Shima M, Makris M, Jiménez-Yuste V, Oldenburg J, Fischer K, Iorio A, Skinner MW, Santagostino E, von Mackensen S, Kessler CM | 2020 | Haemophilia | View Challenges and key lessons from the design and implementation of an international haemophilia registry supported by a pharmaceutical company | Researchers | Clinical research |
COVID-19 versus HIT hypercoagulability | Warkentin TE, Kaatz S | 2020 | Thromb Res | View COVID-19 versus HIT hypercoagulability | Health care providers | Clinical research |
Inhibition of platelet phagocytosis as an in vitro predictor for therapeutic potential of RBC antibodies in murine ITP | Khan R, Menard M, Jen C-C, Chen X, Norris PAA, Lazarus AH | 2020 | Blood | View Inhibition of platelet phagocytosis as an in vitro predictor for therapeutic potential of RBC antibodies in murine ITP | Researchers | Basic research |
Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients | Isho B, Abe KT, Zuo M, Jamal AJ, Rathod B, Wang JH, Li Z, Chao G, Rojas OL, Bang YM, Pu A, Christie-Holmes N, Gervais C, Ceccarelli D, Samavarchi-Tehrani P, Guvenc F, Budylowski P, Li A, Paterson A, Yue FY, Marin LM, Caldwell L, Wrana JL, Colwill K, Sicheri F, Mubareka S, Gray-Owen SD, Drews SJ, Siqueira WL, Barrios-Rodiles M, Ostrowski M, Rini JM, Durocher Y, McGeer AJ, Gommerman JL, Gingras AC | 2020 | Sci Immunol | View Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients | Researchers | Clinical research |
Risk-assessment models for VTE and bleeding in hospitalized medical patients: an overview of systematic reviews | Darzi AJ, Repp AB, Spencer FA, Morsi RZ, Charide R, Etxeandia-Ikobaltzeta I, Bauer KA, Burnett AE, Cushman M, Dentali F, Kahn SR, Rezende SM, Zakai NA, Agarwal A, Karam SG, Lotfi T, Wiercioch W, Waziry R, Iorio A, Akl EA, Schünemann HJ | 2020 | Blood Adv | View Risk-assessment models for VTE and bleeding in hospitalized medical patients: an overview of systematic reviews | Health care providers | Clinical research |
Coenzyme Q10 attenuates platelet integrin alpha II beta 3 signaling and platelet hyper-reactivity in ApoE-deficient mice | Ya F, Xu XR, Tian Z, Gallant RC, Song F, Shi Y, Wu Y, Wan J, Zhao Y, Adili R, Ling W, Ni H, Yang Y | 2020 | Food Funct | View Coenzyme Q10 attenuates platelet integrin alpha II beta 3 signaling and platelet hyper-reactivity in ApoE-deficient mice | Researchers | Basic research |
Fc?RI and FC?RIII on splenic macrophages mediate phagocytosis of anti-glycoprotein IIb/III autoantibody-opsonized platelets in immune thrombocytopenia | Norris PAA, Segel GB, Burack WR, Sachs UJ, Lissenberg-Thunnissen SN, Vidarsson G, Bayat B, Cserti-Gazdewich CM, Callum J, Lin Y, Branch D, Kapur R, Semple JW, Lazarus AH | 2020 | Haematologica | View Fc?RI and FC?RIII on splenic macrophages mediate phagocytosis of anti-glycoprotein IIb/III autoantibody-opsonized platelets in immune thrombocytopenia | Researchers | Basic research |
Assessment of extracellular vesicles using IFC for application in transfusion medicine | Mykhailova O, Seghatchian J, Acker JP | 2020 | Transfus Apher Sci | View Assessment of extracellular vesicles using IFC for application in transfusion medicine | Researchers | Basic research |
Clinical use of Convalescent Plasma in the COVID-19 pandemic: a transfusion-focussed gap analysis with recommendations for future research priorities | Al-Riyami AZ, Schäfer R, van den Berg K, Bloch EM, Estcourt LJ, Goel R, Hindawi S, Josephson CD, Land K, McQuilten ZK, Spitalnik SL, Wood EM, Devine DV, So-Osman C | 2020 | Vox Sang | View Clinical use of Convalescent Plasma in the COVID-19 pandemic: a transfusion-focussed gap analysis with recommendations for future research priorities | Researchers | Clinical research |
Development and Evaluation of a Whiteboard Video Series to Support the Education and Recruitment of Committed Unrelated Donors for Hematopoietic Stem Cell Transplantation | Li EW, Lee A, Vaseghi-Shanjani M, Anagnostopoulos A, Jagelaviciute G, Kum E, Petraszko T, Elmoazzen H, Allan D, Fingrut W | 2020 | Biol Blood Marrow Transplant | View Development and Evaluation of a Whiteboard Video Series to Support the Education and Recruitment of Committed Unrelated Donors for Hematopoietic Stem Cell Transplantation | Health care providers | New or improved product or process |
The law and problematic marketing by private umbilical cord blood banks | Murdoch B, Marcon AR, Caulfield T | 2020 | BMC Med Ethics | View The law and problematic marketing by private umbilical cord blood banks | Other | Ethical, legal and social implications research |